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Introduction
Kazrin was originally identified because it binds to the N-terminal
domain of the cytolinker periplakin (Groot et al., 2004), which was
previously shown to associate with cortical actin, desmosomes and
the interdesmosomal plasma membrane (DiColandrea et al., 2000;
Karashima and Watt, 2002; Kazerounian et al., 2002). Kazrin
colocalises with periplakin at desmosomes and the interdesmosomal
plasma membrane, although its subcellular distribution is
independent of periplakin (Groot et al., 2004). Thus far, four
transcripts encoding three protein isoforms of kazrin have been
described, arising from alternative splicing of the gene. The three
protein isoforms, kazrinA, kazrinB and kazrinC, have different N-
termini but all contain the coiled-coil domain that is involved in
periplakin binding and all have a putative nuclear-localisation signal
(NLS) (Groot et al., 2004).
Kazrin not only regulates desmosome assembly but also
embryonic development and epidermal terminal differentiation
(Sevilla et al., 2008a; Sevilla et al., 2008b). In preimplantation
mouse embryos, kazrin is found at the nuclear matrix, actin
cytoskeleton and cell-cell junctions (Gallicano et al., 2005). Loss
of kazrin in Xenopus tropicalis embryos causes defects in axial
elongation, muscle and notochord differentiation, and epidermal
morphogenesis (Sevilla et al., 2008b). Cultured human keratinocytes
overexpressing kazrin exhibit a decrease in Rho GTPase activity
and have abnormal cell shape, reduced F-actin content and impaired
desmosome assembly (Sevilla et al., 2008a). The effects of kazrin
overexpression on cell adhesion and the cytoskeleton can be
rescued by expression of activated RhoA. In addition, kazrin
overexpression induces keratinocyte differentiation, whereas kazrin
knockdown inhibits terminal differentiation and stimulates
proliferation. The effects of kazrin knockdown are independent of
alteration in RhoA activity (Sevilla et al., 2008a).
In the present report we characterise a kazrin isoform (kazrinE)
belonging to the liprin protein family (Serra-Pages et al., 1998;
Spangler and Hoogenraad, 2007; Stryker and Johnson, 2007).
Liprins were first identified because of their ability to bind to
leukocyte common antigen-related transmembrane receptor protein
tyrosine phosphatase (LAR) (Serra-Pages et al., 1998) and are
implicated in a range of cellular processes, including synapse
formation (Stryker and Johnson, 2007) and extracellular-matrix
adhesion (Asperti et al., 2009). Our observations suggest new
mechanisms by which kazrin can regulate cell adhesion, cytoskeletal
organisation and epidermal differentiation.
Results and Discussion
Identification and detection of kazrinE, an alternatively spliced
transcript of kazrin
In searching for the Drosophila orthologue of kazrin, we found
CG11206, which encodes a longer protein than kazrinA, kazrinB
or kazrinC. This led us to identify the corresponding human EST
clone, kazrinE (GenBank accession number NM_201628). The
transcript of kazrinE consists of seven additional exons inserted
into a consensus splice donor-acceptor site in exon 8 (Fig. 1A).
Exons 9 to 15 encode three sterile  motif (SAM) domains, which
form a liprin-homology domain (LHD), the defining characteristic
of liprins (Stryker and Johnson, 2007). As illustrated in the
phylogenetic tree in Fig. 1B, the kazrinE, liprin- and liprin-b genes
arose from a common ancestor.
By quantitative reverse-transcriptase PCR (RT-PCR), kazrinE
mRNA was detected in all human tissues tested, with highest
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kazrinE induces changes in cell shape and stimulates terminal
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terminal differentiation, the keratinocyte microtubule network
undergoes extensive reorganisation; in differentiating
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kazrinE-microtubule interaction contributes to the mechanism
by which kazrin regulates desmosome formation and epidermal
differentiation.
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expression in the spleen and lowest in skeletal muscle (data not
shown). To determine whether individual cell types coexpressed
the different splice variants of kazrin, semi-quantitative RT-PCR
was performed on cultured cells (Fig. 1C). Transcripts of all kazrin
isoforms were expressed in all three cell types examined, with higher
expression of kazrinE in A431 and EJ/28 cells than in primary
human keratinocytes.
The predicted domains of kazrinE are illustrated schematically
in Fig. 1D. It is possible that three forms of kazrinE, containing the
N-terminus of kazrinA, kazrinB or kazrinC, exist; however, thus
far only cDNA clones containing the kazrinA N-terminus have been
identified in searches of public databases (data not shown). KazrinE
and the shorter isoforms share the coiled-coil domain and putative
nuclear-localisation signal (NLS; at amino acids 376 and 382 in
kazrinA). However, whereas kazrinA, kazrinB and kazrinC share
a common C-terminus, the kazrinE C-terminus contains the LHD
with the three SAM domains located between amino acids 446 and
511, 524 and 588, and 612 and 679. KazrinE also has a PDZ-binding
motif at the extreme C-terminus (amino acids 772-775) (Fig. 1D).
Human kazrinE is highly homologous to the mouse and rat isoforms,
having 90% amino acid identity (BLAST alignment) (Altschul et
al., 1990) (data not shown).
KazrinE interacts with the LAR-type receptor protein tyrosine
phosphatase
Liprin 1 was originally identified by its ability to bind LAR, an
interaction mediated by the SAM domains (Pulido et al., 1995;
Serra-Pages et al., 1995). LAR is known to accumulate at adherens
junctions and desmosomes, via binding to plakoglobin and b-
catenin, and to regulate both junction assembly and b-catenin
signalling (Kypta et al., 1996; Aicher et al., 1997; Muller et al.,
1999). To probe the potential interaction between kazrinE and LAR,
we performed co-immunoprecipitation experiments using total cell
lysates from 293T cells co-transfected with N-terminally
haemagglutinin (HA)-tagged kazrinE and green fluorescent protein
(GFP)-LAR (Fig. 1E). HA-kazrinE and GFP-LAR could be co-
immunoprecipitated from lysates prepared in the presence, but not
in the absence, of phosphatase inhibitors (Fig. 1E), in agreement
with previous work showing that liprin phosphorylation regulates
binding to LAR (Serra-Pages et al., 2005).
To examine whether kazrinE can be tyrosine phosphorylated, we
transfected A431 cells with HA-tagged kazrinE, serum starved the
cells overnight and then treated them for 1 hour with epidermal
growth factor (EGF) (Fig. 1F). Cell lysates were immunoprecipitated
with anti-HA and then immunoblotted with anti-phosphotyrosine
antibody or, as controls for transfection and loading, respectively,
with anti-HA and anti--tubulin (Fig. 1F). On treatment with EGF,
weak tyrosine phosphorylation of kazrinE was detected.
Although the ability of kazrinE to associate with LAR (Fig. 1E)
is predicted from the existence of the LHD and could potentially
be regulated by tyrosine phosphorylation (Fig. 1F), we were unable
to co-immunoprecipitate endogenous LAR and kazrinE in the
presence or absence of phosphatase inhibitors (data not shown).
Furthermore, when the subcellular distribution of GFP-LAR and
HA-kazrinE was compared in transfected primary human
keratinocytes, HA-kazrinE and GFP-LAR showed only partial
colocalisation (Fig. 1G). There was some colocalisation of LAR
and kazrinE at the cell periphery (Fig. 1G). However, HA-kazrinE
accumulated primarily in perinuclear filaments, whereas GFP-LAR
had a more widespread and punctate distribution throughout the
cytoplasm (Fig. 1G). We conclude that, although kazrinE, like liprin-
 family members, can bind LAR, the majority of kazrinE is not
associated with LAR and therefore kazrinE function is unlikely to
be confined to its ability to interact with LAR.
KazrinE expression in epidermis and cultured keratinocytes
In order to analyse endogenous kazrinE expression, we generated
a series of affinity-purified rabbit anti-peptide antibodies that detect
the different kazrin isoforms (Fig. 1D). We tested the specificity of
the antibodies using lysates of 293T cells that had been transfected
with HA-tagged kazrinA, HA-tagged kazrinE or the HA-tagged C-
terminus of kazrinE containing the LHD and PDZ-binding motif
(amino acids 408-775) (Fig. 2A).
Antiserum LS4 was generated against the C-terminal 20 amino
acids common to kazrinA, kazrinB and kazrinC (Groot et al., 2004).
The peptide immunogen thus has only four amino acids in common
with kazrinE. When HA immunoprecipitates from transfected 293T
lysates were immunoblotted with LS4, a single band of
approximately 50 kD, corresponding to kazrinA, was detected (Fig.
2A). By contrast, the LS7 antiserum, raised against a peptide
common to all kazrin isoforms (Fig. 1D), detected bands
corresponding to both kazrinA and kazrinE (Fig. 2A). KazrinE had
a mobility of approximately 105 kD, which is larger than the
predicted molecular mass of 86 kD; this might reflect the
conformation of the protein or post-translational modification, for
example by phosphorylation. LS10, raised against a kazrinE-
specific peptide (Fig. 1D), detected full-length kazrinE and the
kazrinE LHD, but not kazrinA (Fig. 2A).
When extracts of A431 cells, EJ/28 cells and human keratinocytes
were immunoblotted with LS7, bands corresponding to kazrinA and
kazrinB (50 kD), kazrinC (37 kD) and kazrinE (approximately 105
kD) were observed (Fig. 2B). Endogenous kazrinE had the same
mobility as HA-kazrinE (c.f. Fig. 2A,B). In addition, we detected
a higher-molecular-mass protein of approximately 150 kD (Fig. 2B),
which might correspond to complexes of the long and short forms
of kazrin.
We previously observed that the abundance of the short kazrin
isoforms increases as terminally differentiated cells accumulate
during Ca2+-induced stratification of primary human epidermal
keratinocytes in culture (Sevilla et al., 2008a). To examine kazrinE
expression, human keratinocytes grown under standard (‘high
calcium’) conditions were harvested at 50, 80 or 100% confluence,
or 3 days post-confluence (+3D) and immunoblotted with LS10.
The abundance of kazrinE was reduced in post-confluent cultures
(Fig. 2C), suggesting either that its expression decreases during the
later stages of terminal differentiation or that, like the short kazrin
isoforms, it becomes incorporated into the cornified envelope (Groot
et al., 2004).
We next immunolabelled sections of human epidermis with
antibodies to kazrinE and desmoplakin, a desmosome marker (Fig.
2D). Desmoplakin staining was observed in all the living suprabasal
layers of human interfollicular epidermis (Mils et al., 1992). By
contrast, kazrinE was expressed most highly in the basal to mid-
spinous layers and decreased in the upper spinous layers (Fig. 2D).
KazrinE was expressed both at cell-cell borders, where it showed
partial colocalisation with desmoplakin, and in the nucleus (Fig. 2D).
The dual localisation of endogenous kazrinE at cell-cell borders
and in nuclei was confirmed by immunostaining cultured primary
human keratinocytes grown in standard ‘high calcium’ medium (Fig.
2E). As in the epidermis, partial colocalisation of kazrinE and
desmoplakin was observed (Fig. 2E). In addition to the expected
localisation of kazrinE in the nucleus and cell-cell borders, we also
Journal of Cell Science 122 (22)
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detected kazrinE in a filamentous network in the cytoplasm of some
suprabasal cells that were undergoing terminal differentiation (Fig.
2F).
KazrinE expression causes changes in keratinocyte shape and
stimulates terminal differentiation
Overexpression of the short isoforms of kazrin causes profound
changes in cell shape, reducing the amount of filamentous actin
and decreasing Rho activity (Sevilla et al., 2008a). In addition,
overexpression of kazrinA stimulates keratinocyte terminal
differentiation (Sevilla et al., 2008a). To examine whether kazrinE
had similar effects, primary human keratinocytes were transduced
with a retroviral vector encoding HA-kazrinE or, as a control, GFP.
Transduced cells were identified by GFP fluorescence or staining
with an HA-specific antibody, and MetaMorph software was used
to determine the perimeter and area of individual cells. As described
Fig. 1. KazrinE gene structure and
interaction with LAR. (A)Intron-exon
organisation of the human kazrin gene.
Arrows, translation initiation sites;
TGA, translation termination codon;
AATAAA, polyadenylation signal.
Dashed arrow shows generation of
kazrinE by alternative splicing.
(B)Liprin phylogenetic tree. Dm,
Drosophila melanogaster; Gg, Gallus
gallus; Hs, Homo sapiens; Sc,
Saccharomyces cerevisiae; Xl,
Xenopus laevis. Sc_STE11 is included
as a SAM-domain-containing outlier.
(C)RT-PCR using primers to detect the
kazrin isoforms shown or GAPDH as
an input-level control. HK, human
keratinocytes; –/–, no RNA.
(D)Schematic diagram of kazrinA and
kazrinE. KazrinE is shown with the
kazrinA N-terminus (A). lz, leucine-
zipper-like domain; nls, putative
nuclear-localisation sequence; SAM,
sterile  motif. The location of peptide
immunogens is shown. (E)293T cells
transiently co-transfected with HA-
kazrinE (KE) and GFP-LAR (LAR)
were lysed in the presence (+PI) or
absence (–PI) of phosphatase inhibitors
and either examined directly by anti-
HA immunoblotting (lysate) or
following immunoprecipitation with
anti-GFP (GFP IP). As a control, anti-
GFP alone was added to beads (–).
(F)A431 cells were transiently
transfected with GFP (left-hand lane)
or HA-kazrinE, serum starved for 16
hours and either left untreated (–) or
treated with EGF (+) for 1 hour prior to
lysis in the presence of phosphatase
inhibitors. Upper panels: HA-kazrinE
was immunoprecipitated and
immunoblotted with anti-
phosphotyrosine (p-Tyr) or anti-HA.
Arrow indicates phosphorylated
kazrinE. Lower panels: western blots
of total-cell lysates probed with
antibodies to HA or -tubulin (-Tub)
as controls for transfection and
loading, respectively.
(G)Keratinocytes retrovirally
transduced with HA-kazrinE were
transiently transfected with GFP or
GFP-LAR (green), immunolabelled
with anti-HA antibody (red) and
counterstained with DAPI (blue). The
boxed region is shown at higher
magnification in the right-hand panel.
Scale bar: 10m.
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previously (Sevilla et al., 2008a), the shape of individual cells was
scored as ‘altered’ if they exhibited loss of the normal cuboidal
shape that is characteristic of basal keratinocytes. KazrinE induced
a significant increase in cells with altered morphology; however,
the effect was less pronounced than that of overexpressing kazrinA
(Fig. 2G).
The effect of kazrinE overexpression on terminal differentiation
was measured using three parameters: increased forward and side
scatter, expression of involucrin or expression of transglutaminase
(Sevilla et al., 2008a) (Fig. 2H,I and data not shown). By each
criterion, there was a significant increase in the proportion of
terminally differentiated cells when keratinocytes transduced with
HA-kazrinE were compared with cells transduced with GFP.
Although the effect of kazrinE on cell shape was not as marked as
that of kazrinA, the stimulation of terminal differentiation was
equivalent (Fig. 2G-I and data not shown) (Sevilla et al., 2008a).
Homo- and heterotypic interactions between kazrin protein
isoforms
All kazrin isoforms contain a coiled-coil domain, which could
potentially mediate association of the different isoforms with one
another (Burkhard et al., 2001). In addition, liprin- protein family
members are known to oligomerise via their coiled-coil domains
(Serra-Pages et al., 1998). To examine potential kazrin-kazrin
interactions, we performed co-immunoprecipitations using lysates
from Cos cells co-transfected with N-terminally HA-tagged kazrinA,
B, C or E (H-A, H-B, H-C, H-E) and C-terminally FLAG-tagged
kazrinA, B or C (A-F, B-F, C-F) (Fig. 3A). Control cells were
transfected with the HA-tagged construct together with pCIneo
empty vector (V).
Proteins were immunoprecipitated with antibody against the
FLAG-tag and immunoblotted with anti-HA or anti-FLAG (control
for immunoprecipitation) antibodies (Fig. 3A). The higher-
molecular-mass protein of approximately 150 kD observed in
immunoblots of endogenous kazrin (Fig. 2B) was not evident in
the co-immunoprecipitation experiments (Fig. 3A). FLAG-tagged
kazrinA, B or C were co-immunoprecipitated with HA-tagged
kazrinA, B and C. FLAG-tagged kazrinA was co-
immunoprecipitated with HA-tagged kazrinE. We conclude that all
the kazrin isoforms are capable of interacting with one another.
Endogenous kazrinA, B and C are localized to desmosomes, the
nucleus and cortical actin-based structures, but not to perinuclear
filaments (Groot et al., 2004). Because overexpressed kazrinE can
accumulate in perinuclear filaments (Fig. 1G), we predicted that
overexpression of kazrinE would recruit endogenous kazrinA into
perinuclear filaments. Overexpression of HA-tagged kazrinE did
Journal of Cell Science 122 (22)
Fig. 2. KazrinE expression and function in epidermal
keratinocytes. (A)Lysates of 293T cells transfected with HA-
tagged kazrinA (KA), kazrinE (KE) or the kazrinE C-terminus
(LHD) were immunoblotted with the anti-kazrin antibodies
shown. Ponceau-Red staining shows equal protein inputs.
(B)Immunoblot of A431, EJ/28 and human keratinocyte (HK)
protein lysates probed with LS7 or anti-actin (loading control).
KC, kazrinC; KA/B, kazrinA and B; KE, kazrinE.
(A,B)Positions of molecular-mass markers (kD) are indicated.
(C)Human keratinocytes harvested at 50, 80 or 100%
confluence, or 3 days post-confluence (+3D) and immunoblotted
with LS10 (KE) or anti-actin (loading control). Quantitation of
kazrinE abundance relative to 50%-confluent cells is shown.
(D)Immunofluorescence staining of human epidermis with LS10
(green) and desmoplakin (red) with DAPI nuclear counterstain
(blue). Asterisks indicate nuclear staining. SB, basal epidermal
layer; SS, spinous layer; Gr, granular layer; SC, cornified layer.
(E,F)Keratinocytes grown in standard (‘high calcium’) medium
were immunolabelled with antibodies to desmoplakin (red) or
kazrinE (green). Nuclei were counterstained with DAPI (blue).
(D-F)Scale bars: 10m. (G)Keratinocytes transiently expressing
GFP, HA-kazrinA or HA-kazrinE were scored as ‘altered’ if they
exhibited loss of the normal round or cuboidal shape
characteristic of an undifferentiated keratinocyte, and/or loss of
cortical actin. The total numbers of cells counted were: GFP,
1060; kazrinA, 1084; kazrinE, 985. Data are the means ± s.d. of
three (kazrinE) or eight (GFP and kazrinA) independent
experiments. Statistical significance relative to GFP control was
assessed with the paired Student’s t-test (**P≤0.0005, *P≤0.005).
KazrinA and GFP data have been published previously (Sevilla et
al., 2008a). (H)Quantitation of the percentage of keratinocytes
with high forward (FSC) and side (SSC) scatter, an index of
terminal differentiation. Cells were transduced with GFP or HA-
kazrinE, gated on the GFP- or HA-positive populations and then
analyzed for forward and side scatter. Data are mean ± s.d. of
three independent experiments (unpaired Student’s t-test;
**P≤0.005). (I)Flow cytometry of keratinocytes transduced with
GFP or HA-kazrinE and immunolabelled with anti-
transglutaminase. Blue boxes show cells that are positively
labelled compared with cells stained by secondary antibody
alone. The percentage of cells in gated regions is indicated.
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not affect the endogenous level of kazrinA in keratinocytes, nor did
HA-kazrinA overexpression affect endogenous kazrinE levels (Fig.
3B). Nevertheless, HA-kazrinE recruited endogenous kazrinA into
perinuclear filaments (Fig. 3C), consistent with the ability of the
two proteins to associate with one another (Fig. 3A).
Accumulation of kazrinE in perinuclear filaments is mediated
by the LHD
In order to identify the nature of the kazrinE filaments, we
transiently transfected or stably retrovirally infected low-calcium
cultures of human keratinocytes with N-terminally HA-tagged
kazrinE (Fig. 3D,E). To assess whether the C-terminus of kazrinE
(LHD; containing the three putative SAM domains and the PDZ-
binding motif) was responsible for the filamentous distribution
of kazrinE, we transiently transfected keratinocytes with an N-
terminally HA-tagged LHD construct. The LHD had a similar
distribution to full-length kazrinE and was detected in perinuclear
filaments (Fig. 3D). Because such filaments are not observed on
overexpression of the short kazrin isoforms (Groot et al., 2004;
Sevilla et al., 2008a), we conclude that the LHD is both necessary
and sufficient for accumulation of kazrinE in perinuclear
filaments.
Whereas the kazrinE-containing filaments were predominantly
perinuclear in cells cultured in low-calcium medium, 6 hours after
transfer to standard ‘high calcium’ medium (1.8 mM Ca2+) the
filaments had become finer and showed reduced nuclear association
(Fig. 3E). Over time, the filaments elongated and extended through
the cytoplasm towards the plasma membrane (Fig. 3E). The kinetics
of the change in subcellular distribution were significantly slower
than the kinetics of Ca2+-induced desmosome assembly and
accumulation of the short kazrin isoforms in desmosomes (Groot
et al., 2004; Sevilla et al., 2008a).
KazrinE associates with stabilised microtubules
KazrinE filaments did not colocalise with F-actin, keratins or with
the majority of cytoplasmic microtubules (Fig. 4A). However, they
did show complete colocalisation with stabilised, acetylated
microtubules, both in untreated and nocodazole-treated cells (Fig.
4B and data not shown). In immunoblots, the total level of
acetylated tubulin was the same in control cells and in cells
retrovirally transduced with HA-tagged kazrinE (data not shown).
The microtubule cytoskeleton undergoes major reorganisation
during keratinocyte terminal differentiation, coincident with a
reduction in filamentous actin (Lewis et al., 1987; Lechler and
Fuchs, 2007) (Fig. 4C-F). Whereas, in basal keratinocytes,
microtubules are centrosome-associated (Fig. 4A; Fig. 4C,
arrowheads), in differentiating, suprabasal cells the microtubules
are organised into thick mats and distinctive coils (Fig. 4C, asterisks;
Fig. 3. Association of KazrinE and KazrinA isoforms and
accumulation of kazrinE in cytoplasmic filaments. (A)Lysates
of Cos-7 cells coexpressing different combinations of N-
terminally HA-tagged and C-terminally FLAG-tagged kazrin
isoforms were immunoprecipitated with anti-FLAG antibody
(FLAG IP) and immunoblotted with anti-HA (upper panels) or
anti-FLAG (lower panels). Cells were transfected with pCIneo
empty vector (V), or with HA-tagged kazrinA (H-A), kazrinB
(H-B), kazrinC (H-C) or kazrinE (H-E), in combination with
FLAG-tagged kazrinA (A-F), kazrinB (B-F) or kazrinC (C-F).
5% of each lysate was loaded as a control for expression of the
transfected constructs (lysate). –, antibody alone
immunoprecipitation control. Positions of the kazrin isoforms
and immunoglobulin light chain (Ig) are shown. (B)Lysates of
human keratinocytes transduced with kazrinE, kazrinA or GFP
retroviral vectors were immunoblotted with LS7, anti-HA or
anti-b-tubulin (b-Tub) antibodies. Positions of molecular-mass
markers (kD) are indicated. (C)Human keratinocytes transiently
transfected with HA-kazrinE were immunolabelled with anti-
HA (green) and LS4 (red; to detect endogenous short forms of
kazrin), and counterstained with DAPI. (D)Human
keratinocytes transiently transfected with HA-kazrinE or with
HA-LHD (kazrinE liprin-homology domain and PDZ-binding
motif) were immunolabelled with HA antibody (green) and
counterstained with DAPI (blue). (E)Human keratinocytes
transduced with HA-kazrinE were cultured in low-calcium
medium (0h) and then transferred to standard calcium medium
for the number of hours indicated. Cells were labelled with anti-
HA (green) or periplakin (red) with DAPI nuclear counterstain
(blue). Scale bars: 10m.Jo
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Fig. 4E) (Lewis et al., 1987; Lechler and Fuchs, 2007). The
association of endogenous kazrinE with microtubules was observed
in the uppermost layers of differentiating keratinocytes in culture
(Fig. 4D,F; see also Fig. 2F). There was no colocalisation of
periplakin with microtubules in differentiated cells (Fig. 4C,E).
KazrinE was mainly desmosomal in the lower suprabasal layers,
but in the more differentiated layers the microtubule association
was evident (Fig. 4D,F). The colocalisation of endogenous kazrinE
with microtubules was less pronounced than that of overexpressed
kazrinE, which might explain why an association of the short kazrin
isoforms with microtubules has yet to be observed (Groot et al.,
2004) (data not shown).
We conclude that, in addition to its association with
desmosomes and the nucleus, endogenous kazrinE can associate
with microtubules. The microtubule association is mediated by
the LHD and is a specific feature of differentiating cells. Our
observations add to the emerging concept that the microtubule
cytoskeleton contributes to the regulation of epidermal cell
adhesion and cornified envelope assembly. Microtubule disruption
in human keratinocytes can promote the assembly of adherens
junctions (Kee and Steinert, 2001; Kee et al., 2002) and
incorporation of S100A11 into the cornified envelope is thought
to depend on microtubules (Broome and Eckert, 2004).
Conversely, desmoplakin is required for differentiation-specific
reorganisation of epidermal microtubules, and acts by recruiting
ninein from centrosomes to desmosomes (Lechler and Fuchs,
2007). Our studies identify kazrinE as a novel interactor with
desmosomes and microtubules, and suggest a potential role in
coordinating the onset of differentiation with changes in
keratinocyte adhesion and the cytoskeleton.
Materials and Methods
Sequence analysis
The BLAST 2.0 (NCBI, Bethesda, MD) and BLAT (Golden Path Genome Browser,
Santa Cruz, CA) programs were used to search human and mouse EST databases
and genome sequences. ClustalX software (Larkin et al., 2007) was used to generate
the phylogenetic tree in Fig. 1B.
DNA clones and constructs
The eGFP-LAR construct was kindly provided by Wiljan Hendriks (Nijmegen Centre
for Molecular Life Sciences, The Netherlands). N-terminally HA-tagged kazrinA,
kazrinB and kazrinC in EFplinkHA were described previously (Groot et al., 2004).
C-terminally FLAG-tagged kazrin isoforms were generated using the forward primers
5-GCGGAATTCGCCACCATGATGGAAGACAATAAGCAG-3 (kazrinA), 5-
CGGGAATTCGCCACCATGCGGGCGGCCGACTCGGG-3 (kazrinB) and 5-
GGCGAATTCGCCACCATGAAGGAGATGTTGGCGAAG-3 (kazrinC), in
combination with reverse primer 5-GCGGTCGACTCACTTATCG TCGTCAT -
CCTTGTAATCTCCTCCTCCCCAGTCCGCGTCCTCCTCTAT-3. PCR products
were digested with EcoRI and SalI, and ligated into pCIneo (Invitrogen).
IMAGE clones encoding mouse kazrinA (no. 3667377) and human kazrinE (no.
5242289) in pCMV-Sport6 were obtained from the MRC UK HGMP Resource Centre
and confirmed by sequencing. pCIneo HA-kazrinE was generated by PCR amplifying
kazrinE using primers 5-ATGATGGAAGACAATAAGCAG-3 (forward) and 5-
GCGTCTAGACACGTTGGTGACCTCCAGGCT-3 (reverse), then digesting with
AgeI and XbaI and ligating into similarly digested pCIneo HA-kazrinA (Sevilla et
al., 2008a). pBABEpuro HA-kazrinE was generated by cloning the AgeI-SalI
fragment from pCIneo HA-kazrinE into similarly digested pBABEpuro HA-kazrinA
(Sevilla et al., 2008a).
The C-terminus of kazrinE (nucleotides 1222-2326) was amplified using primers
5-GCGCTCGAGGCCACCATGTACCCCTACGACGTGCCCGACTATGCCGGA -
GGAGGAGACTCGGACAGCCAGTGCA-3 (forward) and 5-GCGTCTAGA -
TTACACGTTGGTGACCTCCA-3 (reverse), digested with XhoI and XbaI, and
ligated into pBluescript. The XhoI-NotI fragment of pBluescript HA-kazrinE-LHD
was cloned into pCIneo.
Cell culture
Primary human keratinocytes (strains kv and kt, passages 2-4) and mouse keratinocyte
lines were cultured, transiently transfected and/or retrovirally infected as previously
described (DiColandrea et al., 2000; Groot et al., 2004; Sevilla et al., 2008a). A431,
Cos-7, EJ/28 and 293T cells were maintained in DMEM with 10% FCS. Transient
transfection of Cos-7, A431 and 293T cells was performed using Superfect (Qiagen),
Lipofectamine (Invitrogen) and FuGENE 6 Transfection Reagent (Roche),
respectively.
Where indicated, cells were treated with 33 M nocodazole (Sigma-Aldrich) or
50 ng/ml recombinant human EGF (Peprotech).
RT-PCR
RNA was prepared using TriReagent (Molecular Research Center). The SuperScript
One-Step RT-PCR with Platinum Taq kit (Invitrogen) was used for semi-quantitative
RT-PCR. Total kazrin mRNA (all isoforms) was amplified using a forward primer
in exon 7 (5-GGCGACAGTCCCGGCCCAGTTCAGAAG-3) and a reverse
primer in exon 8 before the kazrinE splice site (5-CCCTCTGGCGAAGACG -
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Fig. 4. Both endogenous and overexpressed kazrinE associate with acetylated
microtubules. (A)Human keratinocytes transiently transfected with HA-
kazrinE were immunolabelled with anti-HA antibody (green), anti-keratin,
anti-b-tubulin or phalloidin (all red) and counterstained with DAPI (blue).
(B)Human keratinocytes transiently transfected with HA-kazrinE were treated
with 33M nocodazole for 3 hours and immunolabelled with anti-HA
antibody (green) and anti-acetylated-tubulin antibody (red), with DAPI nuclear
counterstain (blue). (C-E)Stratified colonies of human keratinocytes
immunolabelled with anti-b-tubulin (red) and anti-periplakin (PPL; green;
C,E) or kazrinE (green; D,F), with DAPI nuclear counterstain (blue). In C,
both panels show the same colony. Asterisks indicate suprabasal, differentiated
cells; arrowheads indicate basal cells. (F)Upper layers of a stratified colony
immunolabelled for acetylated tubulin (red) and kazrinE (green) with DAPI
nuclear counterstain (blue). Arrows indicate colocalisation of tubulin and
kazrinE. Scale bars: 10m.
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CGGGAGATGGA-3). To selectively amplify the short isoforms, the forward primer
was used in combination with a reverse primer after the kazrinE splice site in exon
8 (5-CACCAGTCCGCGTCCTCCTCTATGTAAT-3). To selectively amplify
kazrinE, the forward primer was combined with a reverse primer in exon 9 (5-
CCAGCTCCACCTGCTGCAGCCGGTCCAT-3). All PCR products were confirmed
by sequencing. Primers specific for human GAPDH mRNA were used to control for
input mRNA levels (Groot et al., 2004).
Antibodies
Mouse monoclonal antibodies were used at the dilutions stated: HA.11 (1:1000; anti-
HA, Covance Research Products), M2 (1:1000; anti-FLAG, Sigma Aldrich), AC40
(1:500; anti-actin, Sigma-Aldrich), LP34 (1:100; specific for keratin filaments) (Lane
et al., 1985), clone 2-28-33 (1:1000; anti-b-tubulin, Sigma-Aldrich), clone 6-11B-1
(1:1000; anti-acetylated-tubulin, Sigma-Aldrich), SY5 (1:100; anti-human involucrin),
BC.1 (1:100; anti-transglutaminase-1, a gift from Robert Rice, University of
California, CA), p-Tyr-100 (1:1000; anti-phosphotyrosine, Cell Signaling) and T6199
(1:2500; anti--tubulin, Sigma-Aldrich). The following rabbit antisera were also used:
Y11 (1:50; anti-HA, Santa Cruz Biotechnology), anti-FLAG (1:100; Sigma-Aldrich),
LS4 (1:100; anti-kazrin) (Groot et al., 2004) and LS7 (1:500; anti-kazrin) (Sevilla et
al., 2008a). For flow cytometry, SY5 and BC.1 were directly conjugated to Alexa
Fluor 633 using the Protein Labeling kit from Invitrogen. HA.11 coupled to Alexa
Fluor 488 was purchased from Covance Research Products.
Amino acids 1646-1693 of human periplakin (KREQRENHLRRSIVVIHPD -
TGRELSPEEAHRAGLIDWNMFVKLRSQEC) were used to generate the TD2 rabbit
antiserum (Määttä et al., 2001). Amino acids 733-750 (SKDPDFHDDYGSLQNEDC)
of human kazrinE were used to generate LS10. Anti-kazrin antibodies were affinity
purified on columns containing their respective immunogens coupled to Amino-Link
Coupling Gel (Perbio).
Secondary antibodies were Alexa-Fluor-488- or -594-conjugated donkey anti-rabbit
or mouse IgG and rabbit anti-goat IgG (Invitrogen; diluted 1:1000), or HRP-conjugated
donkey anti-rabbit or anti-mouse IgG (Amersham Biosciences; diluted 1:4000).
Immunofluorescence staining and microscopy
Immunofluorescence labelling was performed as described previously (DiColandrea
et al., 2000). Samples were examined using a Leica Tandem SP5 laser scanning
confocal microscope equipped with 405 nm, 488 nm and 594 nm lasers and immersion
lenses HC PL APO 20 0.7 IMM, HCX PL APO 40 1.25 Oil and HCX PL APO
63 1.4 Oil (Leica, Heidelberg, Germany). Three-dimensional reconstructions of z-
stacks were made using the Leica Application Suite software. Digital images were
prepared using Adobe Photoshop CS2 software and compiled using Adobe Illustrator
CS2.
Immunoprecipitation and immunoblotting
Cos-7 cells were lysed with ice-cold buffer (0.15 M NaCl, 0.05 M Tris, 5 mM EDTA,
0.5% NP-40) containing protease inhibitors (Roche). A431 cells transfected with
pCINeo–HA-kazrinE or pEGFP-C2, and 293T cells were lysed with ice-cold buffer
(0.15 M NaCl, 0.05 M Tris, 5 mM EDTA, 0.02% NP-40) in the presence of protease
inhibitors (Roche) and in the presence or absence of phosphatase inhibitors as indicated
(PhosphoSTOP tablets, Roche; or 100 mM NaF, 2 mM Na3VO4, 20 mM Na4P2O7).
Insoluble material was sedimented by centrifugation for 10 minutes at 4°C at high
speed in a microcentrifuge. Immunoprecipitation and immunoblotting were performed
as previously described (Groot et al., 2004; Sevilla et al., 2008a).
Flow cytometry
Intracellular staining of keratinocytes for involucrin and transglutaminase 1 was
performed essentially as described previously (Sevilla et al., 2008a). Flow cytometry
was performed with the BD FACSCalibur System (BD Biosciences) using BD
CellQuest software. FlowJo software (Tree Star) was used to further analyse the flow-
cytometry data.
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Note added in proof
A further kazrin isoform, kazrinF, has recently been reported (Wang
et al., 2009).
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